.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Cantor Fitzgerald
Covington
Novartis
UBS
Argus Health
Deloitte
Mallinckrodt
McKesson

Generated: December 15, 2017

DrugPatentWatch Database Preview

VIBRAMYCIN Drug Profile

« Back to Dashboard

Which patents cover Vibramycin, and when can generic versions of Vibramycin launch?

Vibramycin is a drug marketed by Pfizer and is included in four NDAs.

The generic ingredient in VIBRAMYCIN is doxycycline calcium. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxycycline calcium profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
PfizerVIBRAMYCINdoxycycline hyclateCAPSULE;ORAL050007-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerVIBRAMYCINdoxycycline hyclateINJECTABLE;INJECTION050442-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerVIBRAMYCINdoxycycline hyclateCAPSULE;ORAL050007-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
PfizerVIBRAMYCINdoxycyclineFOR SUSPENSION;ORAL050006-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
PfizerVIBRAMYCINdoxycycline calciumSUSPENSION;ORAL050480-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
PfizerVIBRAMYCINdoxycycline hyclateINJECTABLE;INJECTION050442-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Queensland Health
Novartis
Chinese Patent Office
US Department of Justice
Julphar
Moodys
Harvard Business School
AstraZeneca
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot